Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ERO1-like pseudogene is a nonfunctional genomic sequence with similarity to the ERO1-like gene family. Pseudogenes are defined by the presence of disabling mutations (such as frameshifts or stop codons) or the absence of necessary gene regulatory elements, rendering them incapable of producing functional protein. Pseudogenes can occasionally regulate gene expression through RNA-mediated mechanisms, but most—such as ERO1-like pseudogene—lack evidence for functional protein or biological activity[7][1][3]. Pseudogenes sometimes complicate genetic analysis in diagnostics since their sequences can be mistaken for their functional counterparts[4]. There is no evidence that the ERO1-like pseudogene is a therapeutic target or has biomarker value[4][7][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ERO1-like pseudogene.